Evidence map›Paper›PMID 42268434›Full record

ArticleMikrochimica acta2026

A hemoglobin-based nanozyme with ruthenium-induced nanomotor ability exhibiting photothermal and chemodynamic responses.

Gökçe Çoban, Esin Akbay Çetin, İrem Yağmur Gök, Neşen Betül Kaya, Burcu Gökçal Kapucu, M Ali Onur, Mustafa Polat, Çiğdem Kip, Ali Tuncel

Abstract read
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gökçe ÇobanChemical Engineering Department, Hacettepe University, Ankara, 06800, Turkey.
Esin Akbay ÇetinDepartment of Biology, Hacettepe University, Ankara, 06800, Turkey.
İrem Yağmur GökDepartment of Biology, Hacettepe University, Ankara, 06800, Turkey.
Neşen Betül KayaChemical Engineering Department, Hacettepe University, Ankara, 06800, Turkey.
Burcu Gökçal KapucuChemical Engineering Department, Hacettepe University, Ankara, 06800, Turkey.
M Ali OnurDepartment of Biology, Hacettepe University, Ankara, 06800, Turkey.
Mustafa PolatDepartment of Physics Engineering, Hacettepe University, Ankara, 06800, Turkey.
Çiğdem KipChemical Engineering Department, Hacettepe University, Ankara, 06800, Turkey. cigdemg@hacettepe.edu.tr.
Ali TuncelChemical Engineering Department, Hacettepe University, Ankara, 06800, Turkey. atuncel@hacettepe.edu.tr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ruthenium functionalized organometallic nanoparticles (Hb@Ru NPs) ca. 10 nm in size, containing crystalline Ru phases were synthesized by a new, single-stage hydrothermal protocol using hemoglobin (Hb) as the skeleton. Compared to currently reported nanozymes, Ru@Hb NPs demonstrated enhanced catalase- and and peroxidase-mimicking activities, produced superoxide (O

Indexed as

Antineoplastic AgentsHemoglobinsMetal NanoparticlesRutheniumAnimalsApoptosisCell Line, TumorHep G2 CellsHumansPhotothermal TherapyReactive Oxygen SpeciesAntineoplastic AgentsHemoglobinsReactive Oxygen SpeciesRutheniumChemodynamic therapyGlioblastomaHemoglobinNanozymeRuthenium

Identifiers

PMID42268434
PMCPMC13253789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.